Keystone Bioanalytical is a GLP-compliant CRO specializing in quantitative LC-MS/MS method development, validation, and analysis, as well as drug metabolite profiling and identification.
We provide bioanalytical and MetID support for discovery, preclinical, and clinical stage studies. These include ADME, PK, toxicology and clinical trial studies.
Support of small, large, and/or multiple clinical studies. Sample receipt, sample tracking, and sample suppository services. Method development, validation, and sample analysis performed in full compliance with regulatory guidelines. Complete quality assurance auditing at each stage of study. Bioanalytical report for regulatory submission with compliance statements. Interim results reporting and expedited bioanalysis available.
Keystone Bioanalytical has extensive experience at applying bioanalytical techniques for the analysis biomarkers. These include renin activity, fatty acid analysis, aldosterone, angiotensin II, GLP-1, T3 T4, and others. Analysis of biomarkers can be performed in a regulated setting or for research and development.
Keystone Bioanalytical specializes in the analysis of tissue samples for drugs and biomarkers. Our automated tissue homogenization provides optimal accuracy and precision for tissue extractions together with rapid sample processing.
Keystone Bioanalytical has expanded our ligand binding capabilities which include multiple biomarkers.